Instalab

Total IgE Test Blood

Your clearest read on whether your immune system is wired for allergic reactions, beyond what symptoms alone can tell you.

Should you take a Total IgE test?

This test is most useful if any of these apply to you.

Dealing with Unexplained Allergy Symptoms
See whether your immune system is producing excess allergy antibodies before investing in specific allergen testing.
Living with Asthma
This test helps clarify whether your asthma is driven by allergic immune pathways, which guides treatment choices.
On a Biologic for Allergies or Asthma
Track whether your treatment is actually resetting your IgE biology, not just masking symptoms.
Healthy but Building an Immune Baseline
Having your IgE number on file now means you will catch meaningful shifts before symptoms appear.

About Total IgE

If you have ever wondered whether your body is primed for allergic reactions, even when you are not sneezing or breaking out in hives, total IgE (immunoglobulin E) is the number that answers that question. It measures the total amount of a specific type of antibody circulating in your blood, one that sits on the surface of your immune defense cells, ready to trigger inflammation the moment it encounters something your body considers a threat.

What makes this test valuable is not just what a high number tells you, but what a very low number might reveal. While most people associate IgE with allergies, emerging research links extremely low levels to a higher risk of certain cancers. This is not a simple "lower is better" marker. Understanding your number, and where it falls relative to your age, gives you a more complete picture of your immune system's posture.

What IgE Actually Does in Your Body

IgE is one of five major classes of antibodies your body makes. It is produced by a type of white blood cell called a B cell, after that cell receives specific chemical signals from helper T cells. The two key signals are proteins called IL-4 and IL-13, which act as instructions telling B cells to switch their antibody production to the IgE type. This switching process is the biological engine behind allergic sensitization, the process by which your immune system "learns" to react to a substance.

Once produced, IgE latches onto receptors on mast cells and basophils, two types of immune cells stationed throughout your skin, airways, and gut. When an allergen (like pollen, dust mites, or a food protein) bridges two IgE molecules on these cells, the cell releases histamine and other inflammatory chemicals. That is the allergic reaction you feel as itching, swelling, sneezing, or wheezing.

In healthy people without allergies, IgE circulates at very low concentrations compared to other antibodies. Only about 20 to 25% of total IgE in someone with asthma is directed at specific allergens. The rest is a mix of IgE targeting various things your immune system has encountered over your lifetime, including parasites and environmental triggers.

Allergic Disease and Asthma

Children with asthma, allergic rhinitis, food allergy, or atopic dermatitis (eczema) consistently show higher total IgE than their non-allergic peers. In a study of over 2,100 children, IgE levels rose significantly in those with allergic diseases, particularly between ages 0 to 2 and 5 to 12, with boys showing higher levels than girls. Children with multiple allergic conditions or atopic dermatitis had the most pronounced elevations.

In a population study of over 1,300 Taiwanese children, a cutoff of about 77.7 kU/L separated atopic from non-atopic children with strong discriminatory ability (area under the curve of 0.92, meaning the test had a 92% probability of correctly ranking an atopic child higher than a non-atopic child). But for individual allergic diseases like asthma or rhinitis alone, accuracy dropped considerably, with sensitivity ranging from 49 to 78%. A low total IgE was better at ruling out allergy than a high total IgE was at confirming it.

The connection to asthma extends beyond classical allergies. In a study of over 1,200 adults, elevated IgE was a significant risk factor for asthma even in people with no identifiable allergen sensitization, challenging the old idea that non-allergic asthma is entirely separate from IgE biology.

Heart Disease Risk

A finding that surprises many people: higher IgE levels are independently associated with more severe coronary artery disease. In a study of 708 patients undergoing coronary angiography (imaging of the heart's arteries), those with artery disease had significantly higher total IgE than those without. IgE levels climbed further as the number of blocked arteries increased, and this association held after adjusting for traditional cardiovascular risk factors like cholesterol, blood pressure, and diabetes.

This does not mean IgE causes heart disease in the way that LDL cholesterol does. But it suggests that the type of immune activation IgE reflects may contribute to the inflammatory processes that damage artery walls. If your IgE is elevated and you have other cardiovascular risk factors, it adds a piece to the puzzle worth discussing with a cardiologist.

Cancer and Very Low IgE

This is where total IgE becomes more than an allergy test. In published pediatric studies, children with very low IgE levels (below approximately 2.5 kU/L) had significantly higher odds of having a blood cancer such as leukemia or lymphoma compared to children with higher IgE levels. The prevalence of cancer in very low IgE groups was many times higher than in children with normal or elevated IgE.

Separately, several studies of brain tumors have found that people with moderately elevated IgE before diagnosis had meaningfully lower odds of developing glioma (a type of brain cancer) compared to those with very low IgE. In studies of glioma patients, above-normal total IgE was also associated with lower mortality risk, particularly in the most aggressive tumor types. These associations held after adjusting for smoking and other factors.

These findings suggest that IgE may play a role in immune surveillance against tumors. Very low IgE is not simply "normal"; it may signal an immune system that is less active in ways that extend beyond allergy.

IgG4-Related Disease

IgG4-related disease is a condition where immune cells infiltrate and damage organs like the pancreas, salivary glands, and bile ducts. In a cohort of newly diagnosed patients followed for a median of approximately 41 months, elevated baseline IgE at diagnosis identified those at high relapse risk with 88% specificity. Higher IgE also correlated with more organs being involved and greater disease activity at diagnosis.

Reference Ranges

Total IgE changes significantly with age, making age-specific interpretation essential. The ranges below come from a US study of 1,376 healthy individuals measured by ImmunoCAP immunoassay, following standard clinical laboratory reference interval protocols. These are orientation values. Your lab may use slightly different cutpoints depending on their assay platform and the population it was calibrated against.

Age GroupReference Range (IU/mL)Notes
Children (varies by age)Rises from low single digits in infancy to peak around age 10Upper limits increase with each age bracket through childhood
Adolescents (16 to 17 years)2 to 537
Adults (18+ years)2 to 214
Very lowBelow 2 to 3May signal immune dysregulation or warrant further evaluation
Very elevatedAbove 500Consider allergic bronchopulmonary aspergillosis, severe atopy, parasitic infection, or immune disorder

Sex partitioning was not required in the reference interval study, meaning the same ranges apply to both men and women. In allergy clinic populations boys tend to have higher IgE than girls, but this likely reflects disease burden rather than a biological need for separate reference ranges. Ethnicity-specific cutpoints have not been formally established, though guidelines acknowledge that population differences likely exist.

Compare your results within the same lab over time for the most meaningful trend. Different assay platforms (ImmunoCAP, Roche, ELISA kits) can produce meaningfully different numbers for the same sample.

When Results Can Be Misleading

The most common source of misinterpretation is not a testing artifact but a conceptual one: treating total IgE as if it tells you which allergen is causing your symptoms. It does not. A high total IgE means your immune system is producing more of this antibody class overall, but it cannot identify whether pollen, dust mites, food proteins, or something else is the trigger. That requires allergen-specific IgE testing or skin prick tests.

  • Biologic therapies: Omalizumab (an anti-IgE drug) causes total measured IgE to rise 3 to 5 fold in the first weeks of treatment because the drug forms complexes with IgE that the standard lab assay still counts. Free, functional IgE drops by over 95%. If you are on omalizumab, your total IgE reading does not reflect your actual allergic activity.
  • Smoking: Smoking independently raises total IgE. In population studies, apparent sex differences in IgE levels largely disappeared when restricted to non-smokers, meaning smoking was the true confounder rather than biological sex.
  • Parasitic infections: Active helminth (worm) infections can drive IgE to very high levels that have nothing to do with environmental allergies. Travel history and exposure risk matter when interpreting an unexpectedly high result.
  • Age mismatch in reference ranges: Some lab systems still use older, lower cutpoints. An adolescent with a level of 300 IU/mL might be flagged as abnormal against an older adult reference range but falls well within the modern age-specific interval for teenagers (upper limit 537 IU/mL). Always check that your result is being compared to the correct age group.

Tracking Your Trend

A single total IgE reading is a snapshot, but your trend over time tells a richer story. In children with allergic diseases, IgE rises through childhood and tracks with the number and severity of allergic conditions. Watching whether your number is climbing, stable, or falling can tell you whether your allergic burden is worsening, responding to treatment, or naturally outgrowing certain sensitivities.

What Moves This Biomarker

Evidence-backed interventions that affect your Total IgE level

Up & Down
Omalizumab (anti-IgE biologic, injected every 2 to 4 weeks, dosed by weight and baseline IgE)
Free IgE in your blood drops by over 95% within weeks, which is the therapeutic goal. However, the total IgE number on your lab report will actually rise 3 to 5 fold initially because the drug binds IgE and forms complexes that the standard assay still counts. Over years of treatment, total IgE gradually declines as the upstream immune signals that drive IgE production begin to reset. The IgE receptors on mast cells and basophils also decrease within 4 weeks, reducing your cells' ability to trigger allergic reactions.
MedicationStrong Evidence
Decrease
Dupilumab (anti-IL-4 receptor biologic, 200 to 300 mg injected every 2 weeks)
By blocking the IL-4 and IL-13 signals that instruct your B cells to produce IgE, dupilumab reduces total IgE by roughly 50 to 60% over 6 to 9 months. In adults with nasal polyps and allergic rhinitis, allergen-specific IgE dropped substantially, with some allergens falling below detection despite ongoing exposure. In peanut-allergic children, both total IgE and peanut-specific IgE fell by roughly half at 24 weeks. This is one of the clearest examples of a drug genuinely reducing IgE production rather than just blocking its effects.
MedicationStrong Evidence
Decrease
Allergen-specific immunotherapy (allergy shots or sublingual tablets, administered over months to years)
Immunotherapy gradually shifts your immune response from IgE-dominated to IgG4-dominated, meaning your body produces blocking antibodies that intercept allergens before they can trigger IgE on mast cells. In patients sensitized to a single allergen who had rhinitis, the ratio of allergen-specific IgE to total IgE predicted treatment success, with higher ratios (above 16.2%) associating with better clinical responses. Combined with omalizumab, immunotherapy achieved near-complete inhibition of IgE-facilitated allergen binding that lasted up to 42 weeks after stopping treatment.
MedicationModerate Evidence
Increase
Cigarette smoking
Smoking independently raises total IgE levels. In population studies, apparent sex differences in IgE largely disappeared when analyses were restricted to non-smokers, revealing smoking as a major confounder. The elevation reflects real immune activation toward the IgE pathway, not just a measurement artifact.
LifestyleModerate Evidence

Frequently Asked Questions

References

21 studies
  1. Katsanakis N, Xepapadaki P, Koumprentziotis IA, Vidalis P, Lakoumentas J, Kritikou M, Papadopoulos NJournal of Clinical Medicine2024
  2. Tu YL, Chang SW, Tsai H, Chen LC, Lee WI, Hua M, Cheng JH, Ou L, Yeh K, Huang JL, Yao TPLoS ONE2013
  3. Di Lorenzo G, Mansueto P, Pacor M, Rizzo M, Castello F, Martinelli N, Ditta V, Lo Bianco C, Leto-barone MS, D'alcamo a, Di Fede G, Rini G, Ditto aThe Journal of Allergy and Clinical Immunology2009
  4. Crespo-lessmann a, Curto E, Mateus E, Soto L, García-moral a, Torrejón M, Belda a, Giner J, Ramos-barbón D, Plaza VPLoS ONE2020
  5. Culver E, Sadler R, Bateman a, Makuch M, Cargill T, Ferry B, Aalberse R, Barnes E, Rispens TClinical Gastroenterology and Hepatology2017